265 related articles for article (PubMed ID: 16458301)
21. Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isolates.
Kosaisavee V; Suwanarusk R; Nosten F; Kyle DE; Barrends M; Jones J; Price R; Russell B; Lek-Uthai U
Exp Parasitol; 2006 Sep; 114(1):34-9. PubMed ID: 16545375
[TBL] [Abstract][Full Text] [Related]
22. Plasmodium vivax malaria in Southeast Iran in 1999-2001: establishing the response to chloroquine in vitro and in vivo.
Hamedi Y; Nateghpour M; Tan-ariya P; Tiensuwan M; Silachamroon U; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):512-8. PubMed ID: 12693585
[TBL] [Abstract][Full Text] [Related]
23. Resistance to chloroquine by Plasmodium vivax at Alor in the Lesser Sundas Archipelago in eastern Indonesia.
Sutanto I; Suprijanto S; Nurhayati ; Manoempil P; Baird JK
Am J Trop Med Hyg; 2009 Aug; 81(2):338-42. PubMed ID: 19635895
[TBL] [Abstract][Full Text] [Related]
24. Infectious diseases. Source of new hope against malaria is in short supply.
Enserink M
Science; 2005 Jan; 307(5706):33. PubMed ID: 15637249
[No Abstract] [Full Text] [Related]
25. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
Kolaczinski K; Durrani N; Rahim S; Rowland M
Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
[TBL] [Abstract][Full Text] [Related]
26. Studies on a primaquine-tolerant strain of Plasmodium vivax from Brazil in Aotus and Saimiri monkeys.
Nayar JK; Baker RH; Knight JW; Sullivan JS; Morris CL; Richardson BB; Galland GG; Collins WE
J Parasitol; 1997 Aug; 83(4):739-45. PubMed ID: 9267419
[TBL] [Abstract][Full Text] [Related]
27. Drug resistance in malaria: three cases and a review.
Isaac-Renton JL; Koon AL; Chan RM; Chow AW; Sacks SL
Can Med Assoc J; 1983 Sep; 129(5):454-7. PubMed ID: 6349767
[TBL] [Abstract][Full Text] [Related]
28. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
[TBL] [Abstract][Full Text] [Related]
29. Effects of different antimalarial drugs on gametocyte carriage in P. vivax malaria.
Pukrittayakamee S; Imwong M; Singhasivanon P; Stepniewska K; Day NJ; White NJ
Am J Trop Med Hyg; 2008 Sep; 79(3):378-84. PubMed ID: 18784229
[TBL] [Abstract][Full Text] [Related]
30. Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial.
Valecha N; Looareesuwan S; Martensson A; Abdulla SM; Krudsood S; Tangpukdee N; Mohanty S; Mishra SK; Tyagi PK; Sharma SK; Moehrle J; Gautam A; Roy A; Paliwal JK; Kothari M; Saha N; Dash AP; Björkman A
Clin Infect Dis; 2010 Sep; 51(6):684-91. PubMed ID: 20687837
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of malaria in Aligarh.
Mehrunnisa A; Wajihullah ; Saifi MA; Khan HM
J Commun Dis; 2002 Mar; 34(1):70-7. PubMed ID: 12718345
[TBL] [Abstract][Full Text] [Related]
32. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.
Price RN; Douglas NM; Anstey NM
Curr Opin Infect Dis; 2009 Oct; 22(5):430-5. PubMed ID: 19571748
[TBL] [Abstract][Full Text] [Related]
33. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of antimalarial action of the synthetic trioxolane RBX11160 (OZ277).
Uhlemann AC; Wittlin S; Matile H; Bustamante LY; Krishna S
Antimicrob Agents Chemother; 2007 Feb; 51(2):667-72. PubMed ID: 17145800
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of DB289 in Thai patients with Plasmodium vivax or acute, uncomplicated Plasmodium falciparum infections.
Yeramian P; Meshnick SR; Krudsood S; Chalermrut K; Silachamroon U; Tangpukdee N; Allen J; Brun R; Kwiek JJ; Tidwell R; Looareesuwan S
J Infect Dis; 2005 Jul; 192(2):319-22. PubMed ID: 15962227
[TBL] [Abstract][Full Text] [Related]
36. [Importance of a regional observatory of malarial chemoresistance, an emerging public health problem in the Guyanas region].
Esterre P; Volney B; Meynard JB; Legrand E
Bull Soc Pathol Exot; 2009 Aug; 102(3):179-84. PubMed ID: 19739416
[TBL] [Abstract][Full Text] [Related]
37. [Artemisinin and successors].
Holzgrabe U
Pharm Unserer Zeit; 2005; 34(2):95. PubMed ID: 15803790
[No Abstract] [Full Text] [Related]
38. A class of potent antimalarials and their specific accumulation in infected erythrocytes.
Wengelnik K; Vidal V; Ancelin ML; Cathiard AM; Morgat JL; Kocken CH; Calas M; Herrera S; Thomas AW; Vial HJ
Science; 2002 Feb; 295(5558):1311-4. PubMed ID: 11847346
[TBL] [Abstract][Full Text] [Related]
39. Enhanced activity of mefloquine and artesunic acid against Plasmodium falciparum in vitro and P. berghei in mice by combination with ciprofloxacin.
Andrade AA; de Pilla Varotti F; de Freitas IO; de Souza MV; Vasconcelos TR; Boechat N; Krettli AU
Eur J Pharmacol; 2007 Mar; 558(1-3):194-8. PubMed ID: 17214980
[TBL] [Abstract][Full Text] [Related]
40. Transmission-blocking activity of tafenoquine (WR-238605) and artelinic acid against naturally circulating strains of Plasmodium vivax in Thailand.
Ponsa N; Sattabongkot J; Kittayapong P; Eikarat N; Coleman RE
Am J Trop Med Hyg; 2003 Nov; 69(5):542-7. PubMed ID: 14695093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
